Skip to main content
SpringerLink
Log in

Remifentanil/rocuronium-bromide

Anaphylaxis: case report

Reactions Weekly volume 1920, page 417 (2022)Cite this article

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

USD 39.95

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Reference

  • Suzuki M, et al. Skin Testing to Identify Safe Drugs for Patients with Rocuronium-Induced Anaphylaxis. Case Reports in Anesthesiology 2020: 2020. Available from: URL: https://www.hindawi.com/journals/cria/

Download references

Rights and permissions

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Remifentanil/rocuronium-bromide. Reactions Weekly 1920, 417 (2022). https://doi.org/10.1007/s40278-022-21954-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-022-21954-9

search

Navigation